CL2015002668A1 - Procesos e intermedios para prepara unmedicamento - Google Patents

Procesos e intermedios para prepara unmedicamento

Info

Publication number
CL2015002668A1
CL2015002668A1 CL2015002668A CL2015002668A CL2015002668A1 CL 2015002668 A1 CL2015002668 A1 CL 2015002668A1 CL 2015002668 A CL2015002668 A CL 2015002668A CL 2015002668 A CL2015002668 A CL 2015002668A CL 2015002668 A1 CL2015002668 A1 CL 2015002668A1
Authority
CL
Chile
Prior art keywords
medication
intermediates
prepare
processes
ibutrinib
Prior art date
Application number
CL2015002668A
Other languages
English (en)
Spanish (es)
Inventor
Ioannis Nicolaos Houpis
Matteo Conza
Philip Pye
Haim Cyril Ben
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50239639&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2015002668(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CL2015002668A1 publication Critical patent/CL2015002668A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
CL2015002668A 2013-03-15 2015-09-14 Procesos e intermedios para prepara unmedicamento CL2015002668A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361786842P 2013-03-15 2013-03-15
EP13159470 2013-03-15
EP13197813 2013-12-17

Publications (1)

Publication Number Publication Date
CL2015002668A1 true CL2015002668A1 (es) 2016-03-04

Family

ID=50239639

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2015002668A CL2015002668A1 (es) 2013-03-15 2015-09-14 Procesos e intermedios para prepara unmedicamento

Country Status (5)

Country Link
CL (1) CL2015002668A1 (zh)
HK (1) HK1216178A1 (zh)
IL (1) IL240533A0 (zh)
PE (1) PE20211448A1 (zh)
PH (1) PH12015502000A1 (zh)

Also Published As

Publication number Publication date
NZ711026A (en) 2021-01-29
PE20211448A1 (es) 2021-08-05
PH12015502000A1 (en) 2016-01-11
HK1216178A1 (zh) 2016-10-21
IL240533A0 (en) 2015-10-29

Similar Documents

Publication Publication Date Title
UY39646A (es) Procedimiento para la preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
ECSP18048718A (es) Imidazolilimidazoles condensados como compuestos antivirales
CR20150370A (es) Compuestos antivirales
CR20160119A (es) Nuevos compuestos y sus composiciones farmacéuticas para el tratamiento de la fibrosis quística
PH12018501094A1 (en) Process for the preparation of an apoptosis-inducing agent
UY34092A (es) Nuevos compuestos como inhibidores de jak
IL236964B (en) Production of volatile dienes by enzymatic dehydration of light alkenols
UY33735A (es) Compuestos antivirales
UY35447A (es) Moduladores de p2x7
CR20160072A (es) Compuestos y composiciones como inhibidores de la mek
EP2785687A4 (en) PROCESS FOR THE PREPARATION OF (3R) -2,4-DI-GROUP-3-METHYLBUT-1-ENE GROUP
UY34212A (es) Derivados de piridin-2(1h)-ona como inhibidores de jak
DOP2013000226A (es) Imidazopiridazinas como inhibidores de quinasa akt.
ZA201406494B (en) Methods of producing sulfilimine compounds
BR112017009289A2 (pt) métodos de administrar composições de amantadina
EA201491446A1 (ru) Способы получения пиперазинового пролекарства - ингибитора прикрепления вич
MY191759A (en) Processes for the preparation of pyrimidinylcyclopentane compounds
CO7071133A2 (es) Diaminopirimidinas utiles como inhibidores del virus sincicial respiratorio (rsv) humano
EA201590594A1 (ru) Макролидные производные, их получение и их терапевтическое использование
BR112014012595A2 (pt) processo de racemização de ácido (s)-3-carbamoilmetil-5-metil-hexanoico
EA201391459A1 (ru) Режимы лечения
CL2015002668A1 (es) Procesos e intermedios para prepara unmedicamento
MX2015017747A (es) Proceso para producir 2-fenil-1, 3-benzoxazoles.
IN2014DN07498A (zh)
CL2012003578A1 (es) Proceso para preparar compuestos derivados de acido gama-amino-delta-bifenil-alfa-metil-alcanoico; y compuestos derivados de acido gama-amino-delta-bifenil-alfa-metil-alcanoico.